We report new assays of enzymes uroporphyrinogen decarboxylase (UROD) and coproporphyrinogen III oxidase (CPO) in the heme biosynthetic pathway. The assays were developed for use in clinical diagnostics of inherited disorders porphyria cutanea tarda and hereditary coproporphyria, respectively. Electrospray ionization tandem mass spectrometry is used to monitor the decarboxylation of pentaporphyrinogen I or uroporphyrinogen III catalyzed by UROD and to determine the enzyme activity in human erythrocytes by measuring the production of coproporphyrinogen I or III. The Km value for pentaporphyrinogen I was measured as 0.17 ± 0.03 μM. A mass spectrometric assay was also developed for the two-step decarboxylative oxidation of coproporphyrinogen III to protoporphyrinogen IX catalyzed by CPO in mitochondria from human lymphocytes (Km = 0.066 ± 0.009 μM). The assays show good reproducibility, use simple workup by liquid−liquid extraction of enzymatic products, and employ commercially available substrates and internal standards.
我们报告了血红素
生物合成途径中尿
卟啉原脱羧酶(UROD)和共
卟啉原 III 氧化酶(CPO)的新测定方法。所开发的检测方法分别用于遗传性皮肤
卟啉症和遗传性共
卟啉症的临床诊断。电喷雾离子化串联质谱法用于监测由 UROD 催化的五
卟啉原 I 或尿
卟啉原 III 的脱羧过程,并通过测定共
卟啉原 I 或 III 的生成量来确定人红细胞中酶的活性。经测定,五
卟啉原 I 的 Km 值为 0.17 ± 0.03 μM。此外,还开发了一种质谱测定法,用于测定人淋巴细胞线粒体中 CPO 催化的共
卟啉原 III 到
原卟啉原 IX 的两步脱羧氧化反应(Km = 0.066 ± 0.009 μM)。这些检测方法具有良好的重现性,通过液-液萃取酶产物进行简单的处理,并采用市售底物和内标。